PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC

Clinical trial NCT06195527 · RECRUITING

Trial details

NCT number: NCT06195527
Sponsor: University Hospital, Angers
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2025-12-17
Primary completion: 2028-06-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.